Hanson McClain Advisors »

Lexeo Therapeutics shares owned by Hanson McClain Advisors

Quarter-by-quarter ownership of Lexeo Therapeutics (LXEO) shares owned by Hanson McClain Advisors from 13F filings

Historical chart of Hanson McClain Advisors investment in Lexeo Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Lexeo Therapeutics held by Hanson McClain Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexeo Therapeutics by Hanson McClain Advisors

Quarter filed Position value Share count Share price at filing
2026-06-30 $913 196 4.66
2026-03-31 $2.2k 379 5.74
2025-12-31 $34k 3.4k 9.93
2025-09-30 $2.0k 307 6.64

More positions owned by Hanson McClain Advisors

Vanguard Index Fds Total Stk Mkt (VTI)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Spdr Series Trust ST STR P500GRW (SPYG)
Vanguard Bd Index Fds Short Trm Bond (BSV)
Spdr Index Shs Fds St Str Po Ex Etf (SPDW)
Spdr Series Trust St Str P500val (SPYV)
Apple Call Call Option (Principal) (AAPL)
J P Morgan Exchange Traded F Active Bond Etf (JBND)
Ishares Tr Us Treas Bd Etf (GOVT)
Vanguard Index Fds Mid Cap Etf (VO)
Spdr Index Shs Fds St Port Mark Etf (SPEM)
Nvidia Corporation Call Call Option (Principal) (NVDA)
Ishares Tr Core S&p Ttl Stk (ITOT)
Ishares Tr Mbs Etf (MBB)
Dimensional Etf Trust Us Cor Equ 2 Etf (DFAC)

View all positions for Hanson McClain Advisors

Top funds holding Lexeo Therapeutics

Suvretta Capital Management
Affinity Asset Advisors
BlackRock
RA Capital Management
Henderson Group
Frazier Life Sciences Management
Vestal Point Capital
Paradigm Biocapital Advisors
Jupiter Topco
OrbiMed Advisors
Citadel Advisors
State Street Corporation
Vanguard Capital Management
Millennium Management
Woodline Partners

View all funds holding Lexeo Therapeutics